vs
Side-by-side financial comparison of BridgeBio Pharma, Inc. (BBIO) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.
BridgeBio Pharma, Inc. is the larger business by last-quarter revenue ($154.2M vs $104.1M, roughly 1.5× GRID DYNAMICS HOLDINGS, INC.). GRID DYNAMICS HOLDINGS, INC. runs the higher net margin — -1.4% vs -126.2%, a 124.8% gap on every dollar of revenue. On growth, BridgeBio Pharma, Inc. posted the faster year-over-year revenue change (2521.2% vs 3.7%).
Brent Saunders is an American biopharma executive and entrepreneur who is the chairman and CEO of the health company Bausch & Lomb. He helped lead various mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He founded the special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthet...
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
BBIO vs GDYN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $154.2M | $104.1M |
| Net Profit | $-194.6M | $-1.5M |
| Gross Margin | 94.7% | 34.8% |
| Operating Margin | -90.5% | 61.7% |
| Net Margin | -126.2% | -1.4% |
| Revenue YoY | 2521.2% | 3.7% |
| Net Profit YoY | 27.2% | -150.6% |
| EPS (diluted) | $-1.00 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $104.1M | ||
| Q4 25 | $154.2M | $106.2M | ||
| Q3 25 | $120.7M | $104.2M | ||
| Q2 25 | $110.6M | $101.1M | ||
| Q1 25 | $116.6M | $100.4M | ||
| Q4 24 | — | $100.3M | ||
| Q3 24 | — | $87.4M | ||
| Q2 24 | — | $83.0M |
| Q1 26 | — | $-1.5M | ||
| Q4 25 | $-194.6M | $306.0K | ||
| Q3 25 | $-184.9M | $1.2M | ||
| Q2 25 | $-183.8M | $5.3M | ||
| Q1 25 | $-169.6M | $2.9M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $-817.0K |
| Q1 26 | — | 34.8% | ||
| Q4 25 | 94.7% | 34.0% | ||
| Q3 25 | 94.6% | 33.3% | ||
| Q2 25 | 96.7% | 34.1% | ||
| Q1 25 | 97.7% | 36.8% | ||
| Q4 24 | — | 36.9% | ||
| Q3 24 | — | 37.4% | ||
| Q2 24 | — | 35.6% |
| Q1 26 | — | 61.7% | ||
| Q4 25 | -90.5% | 0.5% | ||
| Q3 25 | -120.3% | -0.2% | ||
| Q2 25 | -121.4% | -0.1% | ||
| Q1 25 | -89.5% | -2.0% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 0.0% |
| Q1 26 | — | -1.4% | ||
| Q4 25 | -126.2% | 0.3% | ||
| Q3 25 | -153.2% | 1.1% | ||
| Q2 25 | -166.2% | 5.2% | ||
| Q1 25 | -145.4% | 2.9% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | -1.0% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | $-1.00 | $0.01 | ||
| Q3 25 | $-0.95 | $0.01 | ||
| Q2 25 | $-0.95 | $0.06 | ||
| Q1 25 | $-0.88 | $0.03 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | — | $0.05 | ||
| Q2 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $570.1M | $327.5M |
| Total DebtLower is stronger | $2.0B | — |
| Stockholders' EquityBook value | $-2.1B | $530.1M |
| Total Assets | $936.0M | $605.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $327.5M | ||
| Q4 25 | $570.1M | $342.1M | ||
| Q3 25 | $643.0M | $338.6M | ||
| Q2 25 | $756.9M | $336.8M | ||
| Q1 25 | $540.6M | $325.5M | ||
| Q4 24 | — | $334.7M | ||
| Q3 24 | — | $231.3M | ||
| Q2 24 | — | $256.0M |
| Q1 26 | — | — | ||
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $530.1M | ||
| Q4 25 | $-2.1B | $542.1M | ||
| Q3 25 | $-1.9B | $537.7M | ||
| Q2 25 | $-1.8B | $532.2M | ||
| Q1 25 | $-1.6B | $517.4M | ||
| Q4 24 | — | $517.8M | ||
| Q3 24 | — | $400.2M | ||
| Q2 24 | — | $388.4M |
| Q1 26 | — | $605.0M | ||
| Q4 25 | $936.0M | $612.9M | ||
| Q3 25 | $998.3M | $613.2M | ||
| Q2 25 | $1.1B | $608.9M | ||
| Q1 25 | $881.6M | $590.9M | ||
| Q4 24 | — | $592.2M | ||
| Q3 24 | — | $477.3M | ||
| Q2 24 | — | $443.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-56.4M | — |
| Free Cash FlowOCF − Capex | $-56.5M | — |
| FCF MarginFCF / Revenue | -36.6% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-56.4M | $9.9M | ||
| Q3 25 | $-109.6M | $7.0M | ||
| Q2 25 | $-80.7M | $14.4M | ||
| Q1 25 | $-199.2M | $9.4M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | — | $9.2M | ||
| Q2 24 | — | $10.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-56.5M | $6.1M | ||
| Q3 25 | $-110.0M | $2.9M | ||
| Q2 25 | $-81.3M | $10.2M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | — | $5.9M | ||
| Q2 24 | — | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | -36.6% | 5.7% | ||
| Q3 25 | -91.2% | 2.8% | ||
| Q2 25 | -73.5% | 10.1% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 3.6% | ||
| Q3 25 | 0.4% | 3.9% | ||
| Q2 25 | 0.5% | 4.1% | ||
| Q1 25 | 0.0% | 3.3% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.34× | ||
| Q3 25 | — | 5.92× | ||
| Q2 25 | — | 2.73× | ||
| Q1 25 | — | 3.21× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
